Biocompatibility of New Drug-eluting Biodegradable Urethral Stent Materials

Urology

Volumn 75, Issue 1, 2010, Pages 229-234

  Kotsar, Andres ^a   Nieminen, Riina ^b   Isotalo, Taina ^c   Mikkonen, Joonas ^d   Uurto, Ilkka ^a   Kellomäki, Minna ^d   Talja, Martti ^c   Moilanen, Eeva ^a   Tammela, Teuvo L J ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^c PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; DEXAMETHASONE; INDOMETACIN; INTERLEUKIN 8; LATEX; POLYLACTIC ACID; SILICONE; SIMVASTATIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG ELUTING STENT; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL RABBIT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; TISSUE REACTION; URETHRA STENT;

ABSORBABLE IMPLANTS; ANIMALS; CELLS, CULTURED; DRUG-ELUTING STENTS; HUMANS; MALE; MATERIALS TESTING; RABBITS; URETHRA;

EID: 72249109864     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.03.016     Document Type: Article

References (24)

1. Kemppainen E., Talja M., Riikelä M., et al. A bioresorbable urethral stent; an experimental study. Urol Res 21 (1993) 235-238
2. Talja M., Välimaa T., Tammela T.L., et al. Bioabsorbable and biodegradable stents in urology. J Endourol 11 (1997) 391-397
3. Isotalo T., Talja M., Tammela T., et al. Cytotoxicity testing of a new caprolactone-coated self-expanding bioabsorbable self-reinforced poly-l-lactic acid urethral stent. Urol Res 27 (1999) 149-152
4. Vainionpää S., Rokkanen P., and Törmälä P. Surgical application of biodegradable polymers in human tissue. Progr Polym Sci 14 (1989) 679-716
5. Isotalo T., Halasz A., Talja M., et al. Tissue biocompatibility of new caprolactone-coated self-reinforced self-expandable poly-l-lactic acid bioabsorbable urethral stent. J Endourol 13 (1999) 525-530
6. Multanen M., Talja M., Tammela T.L.J., et al. Biocompatibility of silver nitrate and ofloxacin coated bioabsorbable SR-PLLA rods. Urol Res 29 (2001) 113-117
7. Laaksovirta S., Laurila M., Isotalo T., et al. Rabbit muscle and urethral in situ biocompatibility properties of the self-reinforced L-lactide-glycolide acid copolymer 80:20 spiral stent. J Urol 167 (2002) 1527-1531
8. Isotalo T., Nuutinen J.-P., Vaajanen A., et al. Biocompatibility properties of a new braided biodegradable urethral stent: a comparison with a biodegradable spiral and a braided metallic stent in the rabbit urethra. BJU Int 97 (2006) 856-859
9. Talja M., Tammela T., Petas A., et al. Biodegradable self-reinforced polyglycolic acid spiral stent in prevention of postoperative urinary retention after visual laser ablation of the prostate-laser prostatectomy. J Urol 154 (1995) 2089-2092
10. Petas A., Talja M., Tammela T., et al. A randomized study to compare biodegradable self-reinforced polyglycolic acid spiral stent to suprapubic catheter and indwelling catheter after visual laser ablation of the prostate. J Urol 157 (1997) 173-176
11. Dahlstrand C., Grundtman S., and Pettersson S. High-energy transurethral thermotherapy for large severely obstructing prostate and the use of biodegradable stents to avoid catheterization after treatment. Br J Urol 79 (1997) 907-909
12. Oesterlink V. Endoscopic urethroplasty with a free skin graft around resorbable polyglycolic acid urethral stent. (abstract). Eur Urol 30 suppl 2 (1996) 668
13. Isotalo T., Tammela T.L.J., Talja M., et al. A bioabsorbable self-expandable self-reinforced poly-l-lactic acid (SR-PLLA) urethral stent in the treatment of recurrent urethral strictures: a preliminary report. J Urol 160 (1998) 2033-2036
14. Isotalo T., Tammela T.L.J., Talja M., et al. A pilot study of a bioabsorbable self-reinforced poly l-lactic acid urethral stent combined with finasteride in the treatment of acute urinary retention from benign prostatic enlargement. BJU Int 85 (2000) 83-86
15. Baert L., Verhamme L., van Poppel H., et al. Long-term consequences of urethral stents. J Urol 150 (1993) 853-855
16. Isotalo T., Nuutinen J.-P., Vaajanen A., et al. Biocompatibility and implantation properties of 2 differently braided, biodegradable, self-reinforced polylactic acid urethral stents: an experimental study in the rabbit. J Urol 174 (2005) 2401-2404
17. Vogt F., Stein A., Rettemeier G., et al. Long-term assessment of a novel biodegradable paclitaxel-eluting coronary polylactide stent. Eur Heart J 25 (2004) 1330-1340
18. Pan M., de Lezo J.S., Medina A., et al. Drug-eluting stents for treatment of bifurcation lesions: A randomized comparison between paclitaxel and sirolimus stents. Am Heart J 153 (2007) 15.e1-15.e7
19. Uurto I., Kotsar A., Isotalo T., et al. Tissue biocompatibility of new biodegradable drug-eluting stent materials. J Mater Sci Mater Med 18 (2007) 1543-1547
20. Swartbol P., Truedsson L., and Norgren L. The inflammatory response and its consequence for the clinical outcome following aortic aneurysm repair. Eur J Vasc Endovasc Surg 21 (2001) 393-400
21. Anjos-Valotta E.A., Martins J.O., Oliveira M.A., et al. Inhibition of tumor necrosis factor-α-induced intercellular adhesion molecule-1 expression in diabetic rats: role of insulin. Inflamm Res 55 (2006) 16-22
22. Otsuka G., Agah R., Frutkin A.D., et al. Transforming growth factor beta 1 induces neointima formation through plasminogen activator inhibitor-1-dependent pathways. Arterioscler Thromb Vasc Biol 26 (2006) 737-743
23. Prescott S.M., McIntyre T.M., Zimmerman G.A., et al. Sol sherry lecture in thrombosis: molecular events in acute inflammation. Arterioscler Thromb Vasc Biol 22 (2002) 727-733
24. Mukaida N., Harada A., and Matsushima K. Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions. Cytokine Growth Factor Rev 9 (1998) 9-23